HealthcareServices

Revenue of the Clinical Diagnostics Market Predicted to Achieve $115.39 Billion by 2030, Driven by 7.1% CAGR

February 23, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the clinical diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Clinical Diagnostics Market in 2026, and what figure is it projected to hit by 2030?

A robust expansion has been observed in the clinical diagnostics market size over the past few years. The market is projected to expand, climbing from $81.74 billion in 2025 to $87.7 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.3%. During the historic period, this growth was primarily driven by the expansion of diagnostic laboratory networks, the proliferation of disease screening programs, an increasing prevalence of infectious and chronic diseases, enhancements in imaging technologies, and the heightened utilization of lab-based testing methods.

The clinical diagnostics market is projected for significant expansion over the coming years, reaching $115.39 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This anticipated growth is driven by factors such as the increasing embrace of precision diagnostics, greater investments in sophisticated imaging systems, the proliferation of home-based diagnostic solutions, the rising need for swift diagnostic accuracy, and enhanced integration of AI in diagnostics. Key trends influencing this period include the wider adoption of molecular and genetic diagnostics, growing demand for quick point-of-care testing, increased merging of imaging with laboratory diagnostics, the development of automated diagnostic platforms, and a heightened emphasis on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18537&type=smp

Which Drivers Are Affecting Market Participation In The Clinical Diagnostics Market?

The growing occurrence of chronic diseases is projected to stimulate the expansion of the clinical diagnostics market moving forward. These conditions are defined as long-term health issues that can generally be managed but not cured, often necessitating continuous medical care and restricting daily life activities. The increasing rate of chronic diseases is predominantly influenced by elements such as unhealthy lifestyles, socioeconomic disparities, and an aging population, which collectively intensify the risk for conditions like heart disease, diabetes, and cancer. Clinical diagnostics are utilized for chronic diseases to accurately identify conditions, track disease progression, manage treatment, detect early complications, customize medicine, evaluate risk factors, and support patient education and self-management. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition in 2023. The prevalence was recorded as 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Hence, the increasing incidence of chronic diseases is a primary driver for the clinical diagnostics market.

What Segment Categories Are Covered In The Clinical Diagnostics Market?

The clinical diagnostics market covered in this report is segmented –

1) By Test: Lab Test, Imaging Test, Other Tests

2) By Product: Instruments, Reagents, Other Products

3) By End User: Hospital Laboratory, Diagnostic Laboratory, Point-Of-Care Testing, Other End Users

Subsegments:

1) By Lab Test: Blood Tests, Urine Tests, Genetic Tests, Biopsy And Cytology Tests

2) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), CT Scan (Computed Tomography), Ultrasound, PET (Positron Emission Tomography) Scan

3) By Other Tests: Molecular Diagnostics, Point-Of-Care Tests, Pregnancy Tests, Allergy Tests

What Trends Are Driving The Growth Trajectory Of The Clinical Diagnostics Market?

Leading companies within the clinical diagnostics sector are concentrating on developing pioneering products, such as sophisticated liquid biopsy assays, to facilitate extensive genomic analysis of solid tumors. A liquid biopsy assay is a minimally invasive procedure that examines blood samples to identify cancer-related biomarkers, including circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), offering insights for diagnosis, treatment monitoring, and personalized medicine. For instance, in November 2023, Illumina Inc., a US-based biotechnology company, introduced TruSight Oncology 500 ctDNA v2, an advanced liquid biopsy assay designed for comprehensive genomic profiling of solid tumors. This innovative assay enables the precise detection of genetic mutations and alterations in tumors, providing detailed understanding of their molecular profile. The assay enhances the capacity to monitor tumor dynamics and modify treatment plans accordingly, thereby improving personalized treatment strategies. Furthermore, the assay is engineered to deliver rapid and reliable results, aiding timely clinical decision-making and advancing the field of cancer diagnostics.

Which Leading Companies Dominate The Clinical Diagnostics Market Share?

Major companies operating in the clinical diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, FUJIFILM Corporation, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S.A., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Ortho Clinical Diagnostics, BioReference Laboratories Inc., NeoGenomics Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Clinical Diagnostics Market?

North America was the largest region in the clinical diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Clinical Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18537&type=smp

Browse Through More Reports Similar to the Global Clinical Diagnostics Market 2026, By The Business Research Company

Tissue Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Point Of Care Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795